COVID-19 vaccine from Anhui earns conditional approval
By Wang Xiaoyu |
chinadaily.com.cn |
Updated: 2022-03-02 17:20
Share
Share - WeChat
China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.
The vaccine uses purified pieces of the virus' protein to trigger an immune response. It is the first vaccine based on this technology to be approved by the top drug regulator.
In total, five COVID-19 vaccines have been approved for public use in China so far.
- Man arrested in Nanjing for secretly filming and sharing explicit videos
- Commemorative events, exhibitions held in Jiangsu to mark 80th anniv. of victory against Japanese aggression, fascism
- Chinese scientists develop non-invasive blood sodium tracker
- International deep space group founded in Anhui
- China activates emergency response to flooding in Zhejiang, Fujian
- Scientists discover how H5N1 virus invades cattle
